I.B. reported receiving personal fees from Sysmex Europe GmbH outside the submitted work. B.W. reported receiving grants from ISAReasarch Center during the conduct of the study. W.H. reported receiving personal fees from Bayer Vital, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Novartis, AstraZeneca, and The Medicines Company outside the submitted work. D.S. reported receiving personal fees from Sanofi, Bayer, Daiichi Sankyo, AstraZeneca, and Pfizer during the conduct of the study. D.J.A. declares that he has received consulting fees or honoraria from Abbott, Amgen, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, CSL-Behring, Daiichi-Sankyo, Eli Lilly, Haemonetics, Janssen, Merck, Novartis, PhaseBio, PLx Pharma, Pfizer, Sanofi and Vectura, outside the present work. D.J.A. also declares that his institution has received research grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Janssen, Matsutani Chemical Industry Co., Merck, Novartis, Osprey Medical, Renal Guard Solutions and Scott R. MacKenzie Foundation. S.K. reported personal fees from Bristol Myers Squibb, personal fees from AstraZeneca, and personal fees from Translumia outside the submitted work. R.H. reported receiving speaker and consultancy fees from Boston Scientific outside the submitted work. C.V. reported receiving personal fees from Boehringer Ingelheim outside the submitted work. M.J. reported receiving personal fees from Biotronik, OrbusNeich, Boston Scientific, Edwards, Recor, AstraZeneca, and Abbott; and grants from Boston Scientific, Edwards, and Amgen, outside the submitted work. F.J.N. reported receiving grants from Abbott Vascular, Boston Scientific, and Biotronic; personal fees and consultancy fees from Daiichi Sankyo, Amgen, Boston Scientific, Meril, Novartis, and Ferrer, outside the submitted work. H.S. reported receiving personal fees from MSD Sharp & Dohme, Amgen, Bayer Vital GmbH, Boehringer Ingelheim, Daiichi Sankyo, Novartis, Servier, Brahms, Bristol Myers Squibb, Medtronic, Sanofi Aventis, Synlab, Pfizer, and Vifor; and grants from AstraZeneca outside the submitted work. S.S. reported receiving grants from DZHK (German Center for Cardiovascular Research) during the conduct of the study; and grants from Else Kröner-Fresenius-Stiftung (Else Kröner-Memorial grant); personal fees from Bayer Vital GmbH, Daiichi Sankyo, and Biopas Laboratoires outside the submitted work. No other disclosures were reported.